DCM Origination Strategy for Investment Bank

What are the usual DCM origination strategies deployed by banks that don't have a balance sheet (i.e. do not provide corporate loans)?

I understand that the DCM businesses in the FIG / SSA space are quite commoditized. Successful DCM origination teams often provide additional value-add (e.g. engaging clients' senior management in strategic discussions), on top of the usual intel (e.g. market and price updates) provided by all the other banks. 

However, corporate issuers usually give the DCM mandates to banks that already have existing relationships (more often than not, lending relationships) with them. In this case, how would a bank without balance sheet/security firms actually compete in the space? 

Some of the examples might have been oversimplified but would love to hear your thoughts on this.

6 Comments
 

They aren’t competitive. Smaller shops may be thrown a co-man role if they can bring in a specific investor. Otherwise a pure advisory bank might negotiate a JBR role as part of the fees in an m&a mandate. Pure advisory shops don’t have the distribution capacity to be real players

 

Even if firms without a balance sheet (e.g. pure advisory banks) try to leverage the M&A angle, I imagine it would still be quite challenging given that the client would usually ask for a bridge-to-bond kind of arrangement. I always wonder how would firms like Morgan Stanley (might be a bad example as I don't know its business well enough), advisory-focused banks, compete in the DCM market? 

If said banks have a strong sales force and/or trading desks, perhaps they could try to bring potential issuers more private placement opportunities and/or liability management ideas (e.g. OMR/tender)?

 

I imagine that (i.e. all about lending) would be quite true for the corporate space. The SSA/FIG DCM space is probably leaning more towards closer/better coverage (e.g. market and pricing updates, constant flow of funding ideas AT1/T2) and occasional reciprocal transactions (e.g. engaging the potential FIG issuer for the bank's issuance).

What if you're the Head of DCM in a bank that has no lending capability? What would you do to build the business? 

 
Most Helpful

Impedit voluptatibus repellat aspernatur aspernatur aliquam incidunt. Qui ullam qui impedit velit voluptatum quasi. Ab esse excepturi et et. Cum voluptatem accusantium maiores incidunt.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”